At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 284 enrolled
Drug / intervention
Dexamethasone +1 moredrug
Likely dose
Dexamethasone 700 μgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dexamethasone Posterior Segment Drug Delivery System Versus Laser Photocoagulation in Patients With Diabetic Macular Edema
In Brief
A Phase 3 clinical trial evaluating Dexamethasone and Laser Photocoagulation for Macular Edema. Completed, enrolled 284 participants across 18 sites in 2 countries.
Detailed Summary
This study will evaluate the safety and efficacy of 700 μg dexamethasone versus laser photocoagulation in participants with diabetic macular edema (DME).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMacular Edema
CountriesChina, Philippines
CollaboratorsTigermed Consulting Co., Ltd
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 2014
Enrollment StartJan 2016
Primary CompletionNov 2019
TodayJul 2026
First PostedApr 23, 2014
Enrollment StartJan 8, 2016
Primary CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 12.2 years ago
Interventions
Dexamethasonedrug
Dexamethasone 700 μg intravitreal injection in the study eye on Day 1, Months 5, and 10.
Laser Photocoagulationprocedure
Laser photocoagulation on Day 1, and on Months 3, 6, and 9, if retreatment indicated.